Cagrilintide
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
Cagrilintide is a long-acting analog of the pancreatic hormone amylin, engineered for extended stability and studied for its role in satiety and body-weight regulation. It is frequently paired with GLP-1 agonists to investigate complementary appetite-control mechanisms.
| Test | Result | Status |
|---|---|---|
| Purity | 99.2% | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 99.2% | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 98.3% | Passed ✓ |
Research Information
Cagrilintide is used to study amylin- and calcitonin-receptor signaling, gastric emptying and appetite regulation in preclinical models. A major research interest is how amylin-receptor activation works alongside GLP-1 signaling, and whether the two pathways produce additive or synergistic effects on food intake and body weight. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
Cagrilintide Research & Studies
What is Cagrilintide?
Cagrilintide is a long-acting synthetic analog of the pancreatic hormone amylin, designed for extended molecular stability in experimental settings. Laboratory research employs it to examine amylin-related peptide signaling and receptor pharmacology. The compound is investigated strictly within in-vitro assays and controlled preclinical model systems. It is supplied exclusively for research use and is not intended for any other application.
Mechanism of Action
Cagrilintide is studied for its engagement of amylin receptors and related calcitonin receptor complexes. Investigators explore how this receptor activation modulates intracellular signaling cascades linked to satiety and gastric emptying in model systems. Its engineered duration of action enables prolonged observation of receptor occupancy and downstream pathway responses. These mechanistic studies often compare amylin-pathway activity with concurrent GLP-1 receptor signaling.
Primary Areas of Research
Research centers on amylin- and calcitonin-receptor signaling as it relates to appetite regulation and energy-balance pathways. Scientists use Cagrilintide to probe gastric emptying dynamics and food-intake control mechanisms in laboratory models. A major focus is whether amylin-receptor activation produces additive or synergistic effects when examined alongside GLP-1 agonists. Such dual-pathway experiments help map complementary hormonal control of satiety signals.
Key Research Findings
Preclinical investigations have established Cagrilintide as a useful tool for characterizing long-acting amylin receptor agonism. Experimental models demonstrate its value in assessing complementary appetite-control pathways when evaluated with GLP-1 receptor agonists. Observations from these studies contribute to understanding multi-hormonal influences on body-weight regulation parameters under controlled conditions. All reported findings remain limited to in-vitro and laboratory research frameworks.
Research Handling and Considerations
Cagrilintide requires standard laboratory handling and storage practices to maintain compound integrity for experimental work. Researchers employ it solely in in-vitro assays and defined preclinical model systems focused on receptor pharmacology. Proper documentation of solvent, concentration, and exposure conditions supports reproducible study design. The material is designated strictly for research use only and carries no authorization for other purposes.
Frequently Asked Questions
Cagrilintide is investigated for activation of amylin receptors and associated calcitonin receptor complexes in laboratory systems.
Explore Other High-Purity Peptides
Semaglutide
Tirzepatide
Retatrutide
